IGC Return on Tangible Equity | IGC PHARMA, INC.

IGC PHARMA, INC. (IGC) Return on Tangible Equity

2026-06-30: Return Tang Equity -153.14%.
2026-03-31: Return Tang Equity -123.29%.
2025-09-30: Return Tang Equity -83.10%.
2025-06-30: Return Tang Equity -110.64%.

Complete source-backed return tang equity history.

Available history: 2011-03-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-153.14%
2026-03-31	-123.29%
2025-09-30	-83.10%
2025-06-30	-110.64%
2025-03-31	-119.28%
2024-12-31	-154.87%
2024-09-30	-184.84%
2024-06-30	-184.56%
2024-03-31	-196.02%
2023-12-31	-167.48%
2023-09-30	-80.17%
2023-06-30	-85.87%
2023-03-31	-80.60%
2022-12-31	-78.66%
2022-09-30	-71.94%
2022-06-30	-74.32%
2022-03-31	-63.57%
2021-12-31	-39.25%
2021-09-30	-36.81%
2021-06-30	-27.66%
2021-03-31	-27.05%
2020-12-31	-42.30%
2020-09-30	-35.39%
2020-06-30	-31.61%
2020-03-31	-27.71%
2019-12-31	-19.27%
2019-09-30	-16.91%
2019-06-30	-15.31%
2019-03-31	-12.20%
2018-12-31	-8.46%
2018-09-30	-17.95%
2018-06-30	-25.39%
2018-03-31	-22.86%
2017-12-31	-27.81%
2017-09-30	-26.61%
2017-06-30	-31.92%
2017-03-31	-25.65%
2016-12-31	-34.04%
2016-09-30	-19.67%
2016-06-30	-23.77%
2016-03-31	-23.04%
2015-12-31	-27.49%
2015-09-30	-27.93%
2015-06-30	-29.08%
2015-03-31	-34.70%
2014-12-31	-28.08%
2014-09-30	-26.86%
2014-06-30	-23.52%
2014-03-31	-22.18%
2013-12-31	-25.10%
2013-09-30	-20.32%
2013-06-30	-16.93%
2013-03-31	-15.60%
2012-12-31	-31.93%
2012-09-30	-50.94%
2012-03-31	-55.87%
2011-12-31	-170.83%
2011-09-30	-382.56%
2011-06-30	-299.73%
2011-03-31	-323.55%

Annual Return Tang Equity

Date	Return Tang Equity
2025-03-31	-119.28%
2024-03-31	-196.02%
2023-03-31	-80.60%
2022-03-31	-63.57%
2021-03-31	-27.05%
2020-03-31	-27.71%
2019-03-31	-12.20%
2018-03-31	-22.15%
2017-03-31	-26.08%
2016-03-31	-22.84%
2015-03-31	-34.82%
2014-03-31	-22.18%
2013-03-31	-15.60%
2012-03-31	-55.87%
2011-03-31	-323.55%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Hepion Pharmaceuticals, Inc. (HEPA)	United States	$0.029B	-0.62
Transcode Therapeutics, Inc. (RNAZ)	United States	$0.029B	-0.12
KYNTRA BIO, INC. (KYNB)	United States	$0.028B	0.17
BeyondSpring Inc. (BYSI)	United States	$0.031B	-10.95
NANOVIRICIDES, INC. (NNVC)	United States	$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)		$0.032B
Propanc Biopharma, Inc. (PPCB)		$0.032B	-0.13
AYTU BIOPHARMA, INC (AYTU)	United States	$0.025B	-1.62
Context Therapeutics Inc. (CNTX)	United States	$0.034B	-1.10
NextCure, Inc. (NXTC)	United States	$0.024B	-0.15